• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Quadrivalent influenza vaccine in the United States

tetano

tetano

Editor, Senior Moderator
Hum Vaccin Immunother. 2013 Nov 14;10(3). [Epub ahead of print]
Quadrivalent influenza vaccine in the United States.
Suryadevara M, Domachowske JB.
Source

State University of New York; Upstate Medical University; Syracuse, NY USA.
Abstract

New strategies to improve influenza vaccines are ongoing. With the recent development of new vaccine formulations, such improvement are have begun to materialize in formulations available to providers and their patients. One of the newest strategies developed has been to broaden the composition of the current influenza vaccine formulations from trivalent products to quadrivalent products. To date, three manufacturers have developed and tested four vaccine formulations for safety and immunogenicity. The growing availability of quadrivalent influenza vaccines is now a well-recognized advance among the growing opportunities to improve influenza prevention.
KEYWORDS:

influenza virus, quadrivalent influenza vaccine

PMID:
24231756
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24231756
 
You must log in or register to reply here.
Back
Top Bottom